Skip to main content
Erschienen in: Pediatric Nephrology 12/2018

29.06.2018 | Letter to the Editor

Should mycophenolate mofetil be administered prior to cyclosporine A as a steroid-sparing agent to children with steroid-dependent nephrotic syndrome?

verfasst von: Shuichiro Fujinaga, Koji Sakuraya

Erschienen in: Pediatric Nephrology | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Excerpt

Sir, …
Literatur
2.
Zurück zum Zitat Fujinaga S, Ohtomo Y, Umino D, Takemoto M, Shimizu T, Yamashiro Y, Kaneko K (2007) A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome. Pediatr Nephrol 22:71–76CrossRef Fujinaga S, Ohtomo Y, Umino D, Takemoto M, Shimizu T, Yamashiro Y, Kaneko K (2007) A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome. Pediatr Nephrol 22:71–76CrossRef
3.
Zurück zum Zitat Sakuraya K. Kakegawa D, Sakurai S, Hirano D, Fujinaga S (2018) Risk factors associated with relapse and hospitalization during periods of febrile infection in children with nephrotic syndrome treated with immunosuppressant [in Japanese] Nihon Shoni Jinzobyo Gakkai Shi 31:1:25–29CrossRef Sakuraya K. Kakegawa D, Sakurai S, Hirano D, Fujinaga S (2018) Risk factors associated with relapse and hospitalization during periods of febrile infection in children with nephrotic syndrome treated with immunosuppressant [in Japanese] Nihon Shoni Jinzobyo Gakkai Shi 31:1:25–29CrossRef
Metadaten
Titel
Should mycophenolate mofetil be administered prior to cyclosporine A as a steroid-sparing agent to children with steroid-dependent nephrotic syndrome?
verfasst von
Shuichiro Fujinaga
Koji Sakuraya
Publikationsdatum
29.06.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 12/2018
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-018-3993-4

Weitere Artikel der Ausgabe 12/2018

Pediatric Nephrology 12/2018 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.